# Fatemeh Chalabianloo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/fatemeh-chalabianloo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 618 |
| Field | Opioid Use Disorder Treatment |
| h-index | 14 |
| i10-index | 20 |
| Last Known Institution | Haukeland University Hospital |
| OpenAlex ID | https://openalex.org/A5041520088 |
| ORCID iD | 0000-0003-1242-1972 |
| Works | 73 |

## Researcher papers

- [Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)](https://scholariq.org/papers/integrated-treatment-of-hepatitis-c-virus-infection-among-people-who-inject-2/)
- [Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)](https://scholariq.org/papers/integrated-treatment-of-hepatitis-c-virus-infection-among-people-who-inject/)
- [Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway](https://scholariq.org/papers/health-related-quality-of-life-of-long-term-patients-receiving-opioid-agonist/)
- [Integrated care of severe infectious diseases to people with substance use disorders; a systematic review](https://scholariq.org/papers/integrated-care-of-severe-infectious-diseases-to-people-with-substance-use/)
- [Pregabalin og misbrukspotensial](https://scholariq.org/papers/pregabalin-og-misbrukspotensial/)
- [Combined Effect of CYP2B6 Genotype and Other Candidate Genes on a Steady-State Serum Concentration of Methadone in Opioid Maintenance Treatment](https://scholariq.org/papers/combined-effect-of-cyp2b6-genotype-and-other-candidate-genes-on-a-steady-state/)
- [Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020](https://scholariq.org/papers/impact-of-clinical-and-sociodemographic-factors-on-fatigue-among-patients-with/)
- [Clinical characteristics of patients with drug hypersensitivity in Norway: a single‐centre study](https://scholariq.org/papers/clinical-characteristics-of-patients-with-drug-hypersensitivity-in-norway-a/)
- [Harm reduction and abstinence-based models for treatment of substance use disorders during the COVID-19 pandemic: a global perspective](https://scholariq.org/papers/harm-reduction-and-abstinence-based-models-for-treatment-of-substance-use/)
- [Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017](https://scholariq.org/papers/dispensation-of-attention-deficit-hyperactivity-disorder-adhd-medications-in/)
- [Prevalence of substance use disorder in individuals with attention deficit/hyperactivity disorder: associations with sex and psychiatric comorbidity](https://scholariq.org/papers/prevalence-of-substance-use-disorder-in-individuals-with-attention-deficit/)

## Researcher topics

- [Opioid Use Disorder Treatment](https://scholariq.org/topics/opioid-use-disorder-treatment/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Pain Management and Opioid Use](https://scholariq.org/topics/pain-management-and-opioid-use/)
- [Substance Abuse Treatment and Outcomes](https://scholariq.org/topics/substance-abuse-treatment-and-outcomes/)
- [HIV, Drug Use, Sexual Risk](https://scholariq.org/topics/hiv-drug-use-sexual-risk/)

## Researcher university

- [Haukeland University Hospital](https://scholariq.org/institutions/haukeland-university-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.